Background After almost 2 years of fighting against SARS-CoV-2 pandemic, the number of
patients enduring persistent symptoms long after acute infection is a matter of concern. This …

Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

Purpose To find out what is known from literature about Long COVID until January 30, 2021.
Methods We undertook a four-step search with no language restriction. A preliminary search …

The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …

Background The mechanisms by which any upper respiratory virus, including SARS-CoV-2,
impairs chemosensory function are not known. COVID-19 is frequently associated with …

Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-
Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The …

Die Deutsche Gesellschaft für Pneumologie hat die AWMFS1-Leitlinie Post-COVID/Long-
COVID initiiert. In einem breiten interdisziplinären Ansatz wurde diese S1-Leitlinie …

Infection with SARS-CoV-2 ranges from an asymptomatic condition to a severe and
sometimes fatal disease, with mortality most frequently being the result of acute lung injury …

Decreased smell function is related to brain health, future mortality, and quality of life. Most
people inflicted with the SARS-CoV-2 virus evidence some measurable smell dysfunction …

Background: Olfactory training is the only evidence-based treatment for post-viral olfactory
dysfunction. Smell disorders after SARS-CoV-2 infection have been attributed to …